ARIPIPRAZOLE LONG-ACTING INJECTION (Abilify Maintena®)
Clinical Indication
Maintenance treatment of schizophrenia in patients currently stabilised on oral aripiprazole
Comments
See the LLR Antipsychotic Prescribing Guide
2 strengths available: 400mg (each month) and 960mg (every 2 months)
Date of classification
September 2022
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .